BDTX analyst estimates
BDTX (BDTX) analyst ratings, the average price target and its range, and every firm's latest call.
- 5 firms rate BDTX: 4 buy, 1 hold, 0 sell.
- The average price target is $8.00 from None analysts, from $8.00 to $8.00.
BDTX analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Jan 16, 2026 | Piper Sandler | Black Diamond Therapeutics price target lowered to $8 from $9 at Piper Sandler | $8.00 |
| Oct 15, 2025 | Stifel Nicolaus | Black Diamond Therapeutics resumed with a Buy at Stifel | $8.00 |
| Sep 3, 2025 | Guggenheim | Black Diamond Therapeutics initiated with a Buy at Guggenheim | $8.00 |
| Jul 31, 2024 | Raymond James | Black Diamond Therapeutics initiated with an Outperform at Raymond James | $20.00 |
| Jun 3, 2024 | Piper Sandler | Piper Sandler Reiterates Overweight Rating on Black Diamond Therapeutics (BDTX) | $12.00 |
| May 16, 2024 | H.C. Wainwright | Black Diamond price target lowered to $11 from $12 at H.C. Wainwright | $11.00 |
| Apr 8, 2024 | Wedbush | Black Diamond Therapeutics (BDTX) PT Raised to $16 at Wedbush | $16.00 |
| Mar 18, 2024 | H.C. Wainwright | Black Diamond Therapeutics (BDTX) PT Raised to $12 at H.C. Wainwright | $12.00 |